Cite
HARVARD Citation
Yacoub, W. et al. (2018). Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study. Alimentary pharmacology & therapeutics. 47 (7), pp. 906-912. [Online].